Viewing Study NCT06620835


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-01-13 @ 1:08 PM
Study NCT ID: NCT06620835
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2024-09-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Sponsor:
Organization: